Ras in cancer and developmental diseases.

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ras genes were the first identified genetic alterations in human cancer.
• Ras proteins are crucial for signaling networks regulating cell proliferation, differentiation, and survival.
• Oncogenic Ras mutations disrupt these pathways, leading to tumor development.

Purpose of the Study:

• To review the contribution of Ras mutations and altered Ras signaling to tumoral and non-tumoral pathologies.
• To update current knowledge on the role of Ras signaling in human diseases.

Main Methods:

• Review of scientific literature on Ras mutations and signaling pathways.
• Analysis of studies linking Ras alterations to cancer and developmental syndromes.
• Examination of Ras pathway involvement in non-tumoral conditions.

Main Results:

• Oncogenic Ras mutations and mutations in other Ras/MAPK pathway components are often mutually exclusive in tumors.
• Germline mutations in Ras pathway components are associated with familial developmental syndromes.
• Defective Ras signaling contributes to diseases like diabetes and inflammatory disorders.

Conclusions:

• Deregulation of Ras-dependent signaling is essential for tumorigenesis.
• Ras pathway alterations are implicated in both cancer and various non-tumoral human pathologies.
• Understanding Ras signaling is critical for diagnosing and treating a range of diseases.